Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Fusion Antibodies (FAB) Share News

12345

Fusion Antibodies strikes follow-on research and development project

6th Feb 2024 11:48

(Alliance News) - Fusion Antibodies PLC on Tuesday said it has won a follow-on project under a collaborative research and development agreement with an unnamed "US-based biotechnology company". Read More

AIM WINNERS & LOSERS: Beeks Financial Cloud is ahead of expectations

6th Feb 2024 10:05

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday. Read More

Fusion Antibodies gets tax credit from UK HMRC for OptiMAL platform

1st Feb 2024 12:00

(Alliance News) - Fusion Antibodies PLC on Thursday announced the receipt of a research & development tax credit from UK HM Revenue & Customs for work performed on the development of its OptiMAL platform and other projects in bioinformatics. Read More

LONDON MARKET CLOSE: FTSE 100 slips as miners hold down index

4th Dec 2023 16:56

(Alliance News) - Stock prices in London closed lower on Monday, with miners and oil firms holding down the FTSE 100 index. Read More

AIM WINNERS & LOSERS: Cornerstone FS to beat 2023 expectations

4th Dec 2023 10:23

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday. Read More

Fusion Antibodies shares fall with revenue despite "positive" outlook

4th Dec 2023 10:22

(Alliance News) - Fusion Antibodies PLC on Monday reported a widened loss and reduced revenue for its latest half year, but said its growth prospects are "increasingly positive". Read More

Fusion Antibodies shares up on deal with US National Cancer Institute

28th Nov 2023 12:09

(Alliance News) - Fusion Antibodies PLC on Tuesday said it has signed a collaboration agreement with the US National Cancer Institute to use its OptiMAL product to discover novel antibodies to treat certain targets. Read More

AIM WINNERS & LOSERS: Totally swings to half-year loss on NHS blow

28th Nov 2023 10:33

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday. Read More

EARNINGS AND TRADING: Wincanton profit down; James Cropper ups payout

9th Nov 2023 12:54

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

EARNINGS: Tan Delta revenue jumps; Kendrick Resources loss widens

29th Sep 2023 21:19

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

IN BRIEF: Fusion Antibodies appoints part-time CFO on cash struggles

24th Aug 2023 12:10

Fusion Antibodies PLC - Belfast-based contract research organisation providing discovery, design and optimisation services for therapeutic antibodies to the healthcare market - Appoints Stephen Smyth as interim chief financial officer with immediate effect. Smyth was previously CFO at Sera Global LP, and has held senior finance positions at Cormark Securities Inc and PricewaterhouseCoopers LLP. He is currently a partner at FPM Accountants Ltd. Read More

AIM WINNERS & LOSERS: Fulcrum Utility to leave AIM as loss widens

21st Aug 2023 10:29

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday. Read More

Fusion Antibodies inks deal with AI learning firm, hails lower costs

21st Aug 2023 09:35

(Alliance News) - Fusion Antibodies PLC on Monday said it signed an agreement with an unnamed artificial intelligence & machine learning company, which it said could cut costs per sequence test significantly. Read More

Fusion Antibodies completes "difficult" restructuring

14th Aug 2023 08:41

(Alliance News) - Fusion Antibodies PLC on Monday said it has completed its restructuring plans, in hopes of reducing annualised costs by about GBP2.2 million. Read More

UK shareholder meetings calendar - next 7 days

1st Jun 2023 15:52

Read More

IN BRIEF: Fusion Antibodies shares drop after placing at 84% discount

19th May 2023 11:43

Fusion Antibodies PLC - Belfast-based contract research organisation providing discovery, design and optimisation services for therapeutic antibodies to the healthcare market - Raises GBP1.6 million through a placing and director subscription of 31.2 million shares at 5 pence per share, which is an 84% discount to the stock's close on Thursday of 32.06p. The placing is run by broker Allenby Capital Ltd. Fusion also launches a separate retail offer via the REX platform of up to 10.0 million shares at the same price, to raise up to an additional GBP500,000. Read More

Fusion Antibodies files patent application for cancer treatment

21st Mar 2023 10:58

(Alliance News) - Fusion Antibodies PLC on Tuesday said it has filed a patent application for a panel of antibodies that bind to an important target for cancer therapeutics. Read More

LONDON MARKET MIDDAY: Mining stocks weigh on blue-chip index

6th Mar 2023 12:16

(Alliance News) - Stock prices in London were largely lower at midday on Monday, with the FTSE 100 trading in the red, weighed down by poor performances by mining stocks. Read More

Fusion Antibodies drops as annual revenue seen significantly lower

6th Mar 2023 10:52

(Alliance News) - Fusion Antibodies PLC on Monday said it expects annual revenue to be significantly below expectations as a result of continued uncertainty in the timings of orders. Read More

AIM WINNERS & LOSERS: Amur to pay dividends after disposal completion

6th Mar 2023 10:48

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday. Read More

12345
FTSE 100 Latest
Value9,515.00
Change88.01